FDA updates cybersecurity guidance for medical device makers

The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The FBI's Internet Crime Complaint Center released an alert May 7 warning of cyber actors exploiting vulnerabilities in end-of-life routers. Routers dated 2010…
Headline
The FBI’s Internet Criminal Complaint Center May 15 released an alert warning of a malicious text and voice messaging campaign involving impersonators…
Headline
In his latest AHA Cyber Intel blog, John Riggi, AHA national advisor for cybersecurity and risk, examines the state of cyber and physical threats in 2025 as…
Headline
Health care had more cyberthreats last year than any other critical infrastructure industry, according to the FBI's 2024 Internet Crime Report released April…
Headline
The National Security Agency April 23 released a report on operational technology systems that includes recommendations for security policies and technical…
Chairperson's File
Cybersecurity and physical threats are unfortunately significant enterprise risks for health care, regardless of size or location. Every hospital, physician…